Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

By Mansi Janine   Yellowlees Ann   Lipscombe Julian   Earl Helena   Cameron David   Coleman Robert   Perren Timothy   Gallagher Christopher   Quigley Mary   Crown John   Jones Alison   Highley Martin   Leonard Robert   Jeffry Evans T.  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 787-794

Springer Publishing Company

Access to resources Recommend Favorite

The Prognosis of Small Primary Breast Cancers

By Kollias J.   Murphy C.A.   Elston C.W.   Ellis I.O.   Robertson J.F.R.   Blamey R.W.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 908-912

Elsevier

Access to resources Recommend Favorite

Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers

By Onda Masamitsu   Emi Mitsuru   Nagai Hisaki   Nagahata Takemitsu   Tsumagari Kouji   Fujimoto Takashi   Akiyama Futoshi   Sakamoto Goi   Makita Masujirou   Kasumi Fujio   Miki Yoshio   Tanaka Toshihiro   Tsunoda Tatsuhiko   Nakamura Yusuke  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 9, 2004-09 ,pp. : 537-545

Springer Publishing Company

Access to resources Recommend Favorite

Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States)

By Li C.I.  

Cancer Causes and Control, Vol. 11, Iss. 9, 2000-11 ,pp. : 805-811

Springer Publishing Company

Access to resources Recommend Favorite

Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age

By Nsouli-Maktabi Hala  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 963-969

Springer Publishing Company

Access to resources Recommend Favorite